期刊文献+

胃癌组织中程序性死亡配体-1和粘蛋白1的表达及相关性 被引量:1

Expression and correlation of PD-L1 and MUC1 in gastric carcinoma tissue
下载PDF
导出
摘要 目的探讨程序性死亡配体-1(programmed death ligand-1, PD-L1)和粘蛋白1(mucin 1, MUC1)在胃癌组织中的表达与临床病理因素间的关系以及两者间的相互关系。方法应用免疫组织化学S-P方法检测PD-L1和MUC1在120例胃癌组织和40例距癌灶边缘5cm以上的正常胃粘膜组织中的表达。结果在正常胃粘膜组织中未见PD-L1阳性免疫反应,在胃癌组织中PD-L1阳性表达率为32.5%(39/120);MUC1在正常胃粘膜组织中的阳性表达率为100%,在胃癌组织中的阳性表达率是65%(78/120)。在胃癌组织中,PD-L1和MUC1表达与肿瘤大小、肿瘤浸润深度及淋巴结转移有关,与患者年龄、性别、肿瘤分化程度及TNM分期无关;PD-L1和MUC1在胃癌组织中的表达呈正相关。结论 PD-L1和MUC1在胃癌组织中的生物学行为以及两者的相关性提示联合检测更有意义。 Objective To investigate the relationship between expression and clinicopathological factors of programmed death ligand-1 (PD-L1) and mucin 1 (MUC1) as well as their correlation in gastric carcinoma. Methods Immunohistochemical staining (S-P method) for PD-L1 and MUC1 protein was performed in 120 cases of gastric carcinoma tissue and 40 cases of normal gastric mucosa tissue at the margin of 5 or more cm from the edge of cancer tissue. Results No PD-L1 positive immunoreactivity was observed in the normal gastric mucosa and the PD-L1 positive rate was 32.5%(39/120) in the gastric carcinoma tissue;MUC1 positive rate was 100% in the normal gastric mucosa and 65%( 78/120) in the gastric carcinoma mucoca. The expression of PD-L1 and MUC1 was correlated with tumor size, depth of tumor invasion and lymph node metastasis, but not correlated with age, gender, tumor differentiation and TNM stage. PD-L1 was positively correlated with MUC1 in the expression level. Conclusion The biological behavior of PD-L1 and MUC1 proteins in gastric cancer tissues and their correlation suggest that the combined detection for both PD-L1 and MUC1 proteins is more meaningful.
作者 陆娜娜 Lu Nana(Department of pathology, the Binhu Hospital of Hefei, Hefei 230601)
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2018年第6期553-558,共6页 Chinese Journal of Histochemistry and Cytochemistry
关键词 胃癌 程序性死亡配体-1 粘蛋白1 Gastric carcinoma programmed death ligand-1 mucin 1
  • 相关文献

参考文献1

二级参考文献39

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) :87-108.
  • 2Swaika A, Hammond WA, Joseph RW, et al. Current state of an- ti-PD-L1 and anti-PD-1 agents in cancer therapy[ J]. Mol Immu- nol, 2015,67(2 Pt A) :4-17.
  • 3Yang CY, Lin MW, Chang YL, et al. Programmed cell death-lig- and 1 expression in surgically resected stage I pulmonary adeno- carcinoma and its correlation with driver mutations and clinical outcomes[J]. Eur J Cancer, 2014,50(7) : 1361-1369.
  • 4Muenst S, Schaerli AR, Gao F, et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer [ J ]. Breast Cancer Res Treat, 2014, 146 (1) :15-24.
  • 5Kim JW, Nam KH, Ahn SH, et al. Prognostic implications of im- munosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer [ J/OL ]. Gastric Cancer, 2014 [ 2015-07-15 ]. http:// www.ncbi, nlm. nih.gov/pubmed/25424150.
  • 6Choueiri TK, Fay AP, Gray KP, et al. PD-L1 expression in non- clear-cell renal cell carcinoma [ J ]. Ann Oncol, 2014, 25 ( 11 ) : 2178-2184.
  • 7Zhang J,Fang W, Qin T, et al. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma[ J]. Med On- col, 2015,32(3) :86.
  • 8Madore J, Vilain RE, Menzies AM, et al. PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials [ J]. Pigment Cell Melanoma Res, 2015,28(3) :245-253.
  • 9D'Angelo SP, Shoushtari AN, Agaram NP, et al. Prevalence of tumor-infiltrating lymphoeytes and PD-L1 expression in the soft tissue sarcoma mieroenvironment [ J ]. Hum Pathol, 2015, 46 (3) :357-365.
  • 10Cho YA, Yoon H J, Lee JI, et al. Relationship between the expres- sions of PD-LI and tumor-infiltrating lymphocytes in oral squamous cell carcinoma[J]. Oral Oncol, 2011, 47(12) :1148 -1153.

共引文献2

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部